Advances in endoluminal therapy for esophageal cancer

Brintha K. Enestvedt, Gregory G. Ginsberg

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Advances in endoscopic therapy have resulted in dramatic changes in the way early esophageal cancer is managed as well as in the palliation of dysphagia related to advanced esophageal cancer. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are effective therapies for accurate histopathologic staging and provide a potential for complete cure. Mucosal ablative techniques (radiofrequency ablation and cryotherapy) are effective adjuncts to EMR and ESD and reduce the occurrence of synchronous and metachronous lesions within the Barrett esophagus. The successes of these techniques have made endoscopic therapy the primary means of management of early esophageal cancer.

Original languageEnglish (US)
Pages (from-to)17-39
Number of pages23
JournalGastrointestinal Endoscopy Clinics of North America
Issue number1
StatePublished - Jan 1 2013


  • Early esophageal cancer
  • Endoscopic mucosal resection
  • Endoscopic submucosal dissection
  • Endoscopic therapy
  • Mucosal ablation
  • Palliation of esophageal cancer
  • Self-expanding metal stents
  • Superficial esophageal cancer

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Advances in endoluminal therapy for esophageal cancer'. Together they form a unique fingerprint.

Cite this